For sure there is a narrative against CYDY, but as is
For sure there is a narrative against CYDY, but as is slowly coming out, the clinical trials were intentionally botched, there was an antipathy at the FDA (almost wrote the conspira--word but stopped short), and abundant, deliberately-misinforming press, based on hidden conflicts of interest.
Lies can get halfway around the globe before the truth can get its pants on.
We have a lot of narrative and prejudice distance to recover, but slowly, step by step, Dr. L. is doing it. For the good of the world, primarily (and we get to come along for the ride).
(BTW Gilead, to name just one big pharma who *isn't* in it for the good of the world primarily, kept its own more effective HIV drug away from patients in favor of a drug they were already selling, so they could maximize profit from the less-effective drug before its patent expired. Seriously. They didn't care. And their defending counsel was S-A, who seems to be everywhere in big pharma cases...)
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Current Landscape Chipotle Mexican Grill (NYSE:CMG) stands at a crossroads, teetering on the edge of a significant market shift. I mean, it's like watching a seesaw in a hurricane. Now, here's the kicker—activist investor Dan Loeb's Third Point LLC jumped in, acquiring a 4.75 million share slice of the fast-casual chain in late 2025, right when CMG’s shares are...
Continue Reading
Hims & Hers Health Set to Join the S&P SmallCap 600 Hims & Hers Health, Inc. (NYSE: HIMS) is making waves in the financial markets as it prepares to join the S&P SmallCap 600. This transition marks a significant milestone for the company, reflecting its growth and stability in the healthcare sector. Details of the Market Transition The effective date for the change is set...
Continue Reading
Examining Spain's Stock Market Trends Recently, Spain's stock market has shown a slight decline, particularly noticeable at the close on a Friday. The key index, the IBEX 35, which tracks the performance of the country's leading companies, experienced a minor drop of 0.11%. This downturn is largely due to losses in important sectors, including Building & Construction,...
Continue Reading
Toll Brothers Presents Final Opportunity in Valencia Toll Brothers, Inc. (NYSE: TOL), recognized as the nation's premier luxury home builder, has announced the final chance for home buyers to purchase a new home at the prestigious Volara community. Nestled within the dynamic Valencia master-planned community, this offering is particularly exciting as there are only five...
Continue Reading
U.S. stock markets turned up the heat back in that session—gains across key sectors painted a picture of resilience, especially in Oil & Gas, Technology, and Healthcare. You could feel the confidence bubbling up among investors, kinda like when you finally hit a good coffee after a long night shift. Dow Jones Soars: New All-Time High or Just a Mirage? The Dow Jones...
Continue Reading